SEC Form 4 · accession 0001179110-18-004691
BeOne Medicines Ltd. · ONC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Howard Liang
Officer — CFO & Chief Strategy Officer
Period of report
Mar 16, 2018
Accepted (ET)
Mar 20, 2018 · 5:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001651308
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| American Depositary SharesF1,F2 | Mar 16, 2018 | M | 10,872 | $6.50 | A | 15,872 | D | |
| American Depositary SharesF1 | Mar 16, 2018 | S | 1,000 | $154.95 | D | 14,872 | D | |
| American Depositary SharesF1,F4 | Mar 16, 2018 | S | 2,208 | $156.7458 | D | 12,664 | D | |
| American Depositary SharesF1,F5 | Mar 16, 2018 | S | 7,264 | $157.4105 | D | 5,400 | D | |
| Amerian Depositary SharesF1,F6 | Mar 16, 2018 | S | 400 | $157.9775 | D | 5,000 | D | |
| American Depositary SharesF1,F2 | Mar 19, 2018 | M | 24,128 | $6.50 | A | 29,128 | D | |
| American Depositary SharesF1,F7 | Mar 19, 2018 | S | 500 | $158.448 | D | 28,628 | D | |
| American Depositary SharesF1,F8 | Mar 19, 2018 | S | 5,200 | $159.6234 | D | 23,428 | D | |
| American Depositary SharesF1,F9 | Mar 19, 2018 | S | 9,618 | $160.6001 | D | 13,810 | D | |
| American Depositary SharesF1,F10 | Mar 19, 2018 | S | 3,141 | $161.6239 | D | 10,669 | D | |
| American Depositary SharesF1,F11 | Mar 19, 2018 | S | 5,133 | $162.7864 | D | 5,536 | D | |
| American Depositary SharesF1,F12 | Mar 19, 2018 | S | 4,636 | $163.4818 | D | 900 | D | |
| American Depositary SharesF1,F13 | Mar 19, 2018 | S | 900 | $164.3589 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F14,F15 | $0.50 | Mar 16, 2018 | M | 141,336 | D | — | Jul 1, 2025 | Ordinary Shares | 141,336 | 4,758,664 | D |
| Share Option (Right to Buy)F14,F15 | $0.50 | Mar 19, 2018 | M | 313,664 | D | — | Jul 1, 2025 | Ordinary Shares | 313,664 | 4,445,000 | D |
Explanation of responses
- F1Each American Depositary Share ("ADS") represents 13 Ordinary Shares.
- F10The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $161.13 to $162.05, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of ADSs sold at each separate price.
- F11The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $162.15 to $163.13, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of ADSs sold at each separate price.
- F12The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $163.16 to $164.15, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of ADSs sold at each separate price.
- F13The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $164.16 to $165.03, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of ADSs sold at each separate price.
- F14The number of securities underlying each option and the exercise price therefor are represented in ordinary shares.
- F15These securities vest over a four-year period as follows: 25% on July 15, 2016, and the remaining in 36 successive equal monthly installments, subject to continued service. All unvested shares subject to this option are subject to accelerated vesting upon a sale event or certain termination events.
- F2The exercise price is represented in ADSs.
- F3The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $155.95 to $156.94, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of ADSs sold at each separate price.
- F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.95 to $157.93, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of ADSs sold at each separate price.
- F6The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $157.97 to $157.98, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of ADSs sold at each separate price.
- F7The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $158.04 to $158.86, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of ADSs sold at each separate price.
- F8The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $159.06 to $160.05, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of ADSs sold at each separate price.
- F9The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $160.07 to $161.05, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of ADSs sold at each separate price.